Connect with us


USA: MedMen declares bankruptcy with 400 million dollars of debt



The North American cannabis giant MEDMAR has collapsed under the weight of its debt, announcing last week that it has declared bankruptcy and plans to liquidate its assets. On April 26, the once successful MSO (multi-state operator) announced that it has filed for bankruptcy under the Canadian Bankruptcy and Insolvency Act and that all of its directors have resigned with immediate effect, following the dismissal from your CFO in February.

Additionally, on April 23, 2024, MedMen's California-based subsidiary, MM CAN USA, was placed into receivership in Los Angeles Superior Court to dissolve and liquidate its assets.

The company's Restructuring Director resigned from his position and was appointed Judicial Administrator of MM CAN USA. Similar bankruptcy proceedings are expected to occur in other US states where the subsidiary operates.

This bankruptcy comes just six years after the company's IPO, seeing the company's value reach a peak of $3 billion in the following months. The company now leaves behind more than $400 million in debt. Like many of its peers, MedMen rode the wave of positive sentiment in 2018, seeing its share price more than double by the end of the year.

The company expanded rapidly, growing to 25 locations in California, Nevada, Illinois, Massachusetts and New York, taking on significant debt in the process. In 2019, MedMen attempted to finalize a $682 million merger with PharmaCann, which ultimately fell apart due to concerns antitrust, leaving the company struggling to pay its creditors.

Scandals continued to dog the business, leading to its founder, Sam Bierman, being ousted in 2020, embroiled in allegations of misuse of company funds. Further legal battles, accusations of racism and increasing competition from legal and illegal cannabis markets plagued MedMen during its fall from grace.

Since its peak, the company's share price has fallen by more than 90% and all but two of its stores have closed.

“The difficult decision to cease operations and initiate bankruptcy and receivership proceedings was made after careful consideration of the current financial situation of the company and its subsidiaries, its inability to pay its obligations when due and the anticipated enforcement actions of guarantee by creditors”, said the company in a press release.

“After careful consideration of these factors and in the absence of other available alternatives, the company's board of directors determined that it was in the company's best interest to proceed with the initiation of bankruptcy and receivership proceedings,” the statement ends.
This article was originally published by Ben Stevens on Business of Cannabis



[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]


What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Click here to comment
Notify of

Inline feedback
View all comments

Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

International1 hours ago

Germany approves first cannabis social club after legalization

The Minister of Agriculture of Lower Saxony, Miriam Staudte, announced this Monday that her office has authorized the first club...

Hemp3 days ago

Thailand increasingly closer to reclassifying cannabis and hemp as controlled substances

Thailand has taken another decisive step towards re-banning cannabis in the country. Last Friday,...

International1 weeks ago

European Monitoring Center for Drugs and Drug Addiction (EMCDDA) becomes the European Union Agency for Drugs (EUDA)

On July 2, 2024, the European Monitoring Center for Drugs and Drug Addiction (EMCDDA) will become the Agency...

Events2 weeks ago

ICRS – International Cannabinoid Research Society brings together doctors and researchers in Salamanca for the 34th Symposium on Cannabinoids

If you think that cannabis research is something recent and that there are still not enough studies… think again! AND...

Crónica2 weeks ago

Terroir 101 – An Introduction

This article begins a series on topics necessary for those who believe that this plant deserves to be revered and elevated...

Events2 weeks ago

CannaReporter® Editor, Laura Ramos, named “Journalist of the Year” at the Business of Cannabis Awards

The cannabis industry is about to gather in London for two days of Cannabis Europe and a night of...

Press Releases3 weeks ago

Cannabis Europe welcomes European and North American leaders to London to capitalize on the European cannabis market

The North American cannabis industry is creating a significant movement across the Atlantic as leaders of this...

International4 weeks ago

German police clarify that they did not suggest the consumption of cannabis (instead of alcohol) to English fans at Euro 2024

The police in Gelsenkirchen, Germany, were cited in a news report stating that attention would be more focused on the fans...

Events4 weeks ago

Synthetic substances threaten Mary Jane Berlin's huge success

It was expected that this edition of Mary Jane Berlin would be the largest gathering ever of the cannabis community in...

National4 weeks ago

ICAD promotes European survey on drug use in Portugal

The Institute for Addictive Behaviors and Addictions (ICAD) has launched the 4th edition of the European Web Survey on Drugs...